Blood pressure load associated with progressive kidney function decline in biopsy-proven atherosclerotic chronic

Hiroki Nobayashi1, Go Kanzaki2, Haruki Mae1

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan.

Insights

Elevated blood pressure (BP) load, even with normal office BP readings, significantly accelerates chronic kidney disease (CKD) progression. Comprehensive 24-hour ambulatory BP monitoring (ABPM) is vital for managing CKD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Hypertension Research

Background:

  • Hypertension is a primary driver of chronic kidney disease (CKD) progression.
  • The specific impact of elevated blood pressure (BP) load, particularly when office BP readings are normal, remains insufficiently understood.
  • This study investigates the influence of elevated BP load in biopsy-proven CKD patients with normal office BP.

Purpose of the Study:

  • To determine the impact of elevated blood pressure (BP) load in patients with biopsy-proven chronic kidney disease (CKD) and normal office BP.
  • To compare outcomes between patients with isolated BP load elevation, hypertension, and normotension.
  • To identify BP load elevation as a risk factor for CKD progression.

Main Methods:

  • Retrospective cohort study involving 57 patients with histologically confirmed atherosclerotic CKD.
  • Utilized 24-hour ambulatory BP monitoring (ABPM) and kidney biopsy data.
  • Classified patients into normotension, isolated BP load elevation, and hypertension groups.

Main Results:

  • Patients with isolated BP load elevation and hypertension exhibited significantly higher rates of adverse kidney events compared to the normotension group (p < 0.01).
  • After adjusting for confounding factors, isolated BP load elevation remained a significant predictor of adverse kidney outcomes (hazard ratio, 9.25).
  • A sustained decline in estimated glomerular filtration rate (eGFR) of ≥30% within 3 years was the primary outcome measure.

Conclusions:

  • Isolated BP load elevation is a significant risk factor for CKD progression, even when office BP is normal.
  • Targeting BP load normalization may offer a therapeutic strategy for managing CKD.
  • 24-hour ABPM is essential for comprehensive CKD assessment, revealing abnormalities missed by conventional BP measurements.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
68
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
78
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
885
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
93